Gene expression patterns induced by HPV-16 L1 virus-like particles in leukocytes from vaccine recipients.
Gene expression patterns induced by HPV-16 L1 virus-like particles in leukocytes from vaccine recipients.
复制标题
DOI:
10.4049/jimmunol.182.3.1706
复制
发表时间:
2009-02-01
期刊:
影响因子:
--
通讯作者:
Pinto LA
中科院分区:
文献类型:
--
作者:
García-Piñeres AJ;Hildesheim A;Dodd L;Kemp TJ;Yang J;Fullmer B;Harro C;Lowy DR;Lempicki RA;Pinto LA
Human papilloma (HPV) virus-like particle (VLP) vaccines were recently licensed. Though neutralizing antibody titers are thought to be the main effectors of protection against infection, early predictors of long-term efficacy are not yet defined and a comprehensive understanding of innate and adaptive immune responses to vaccination is still lacking. Here, microarrays were used to compare the gene expression signature in HPV-16 L1 VLP-stimulated PBMC from 17 vaccine and 4 placebo recipients before vaccination, and 1 month after receiving the second immunization. Vaccination with a monovalent HPV-16 L1 VLP vaccine was associated with modulation of genes involved in the inflammatory/defense response, cytokine, interferon and cell cycle pathways in VLP-stimulated PBMC. Additionally, there was up-regulation of probesets associated with cytotoxic (GZMB, TNFSF10) and regulatory (INDO, CTLA4) activities. The strongest correlations with neutralizing antibody titers were found for cyclin d2 (CCND2) and galectin (LGALS2). Twenty-two differentially expressed probesets were selected for confirmation by RT-PCR in an independent sample set. Agreement with microarray data was seen for over two-thirds of these probesets. Up-regulation of immune/defense response genes by HPV-16 L1 VLP, in particular interferon-induced genes was observed in PBMC collected prior to vaccination, with many of these genes being further induced following vaccination. In conclusion, we identified important innate and adaptive response related- genes induced by vaccination with HPV-16 L1 VLP. Further studies are needed to identify gene expression signatures of immunogenicity and long-term protection with potential utility in prediction of long-term HPV vaccination outcomes in clinical trials.
登录
查看更多内容
影响因子:
3.8
作者:
Kawada, Jun-ichi;Kimura, Hiroshi;Morishima, Tsuneo
通讯作者:
Morishima, Tsuneo
影响因子:
5.5
作者:
Giacalone MJ;Sabbadini RA;Chambers AL;Pillai S;Berkley NL;Surber MW;McGuire KL
通讯作者:
McGuire KL
影响因子:
3.8
作者:
Dodd, Lori E.;Sengupta, Srikumar;Hildesheim, Allan
通讯作者:
Hildesheim, Allan
影响因子:
6.4
作者:
Lempicki, RA;Polis, MA;Kottilil, S
通讯作者:
Kottilil, S
影响因子:
20.3
作者:
Bergsagel, PL;Kuehl, WM;Shaughnessy, J
通讯作者:
Shaughnessy, J